EBS Financial Facts

Weighted-average number of shares - diluted: 49.44M
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
See Full Income Statement

Total assets: 932.03M
Accumulated other comprehensive loss: -3.57M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 2/24/17 *Est. EPS Growth Rate -30.1% *Last Qtr.
Average EPS % Beat Rate +114.3% Revenue Growth Rate -13.3% *Last Qtr.
Average % Move 1-Wk after EPS +1.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/25/16 Q415 $0.78$0.70 +$0.08$168.1M$168.07M N/A Details
11/5/15 Q315 $0.83$0.55 +$0.28$164.9M$151.42M = Details
3/5/15 Q115 $0.75$0.69 +$0.06$148M$147M = Details
11/6/14 Q414 $0.67$0.52 +$0.15$138M$126.9M = Details
8/6/15 Q215 $0.36$0.18 +$0.18$126.1M$114.25M = Details
11/7/16 Q316 $0.58$0.26 +$0.32$142.9M$112.3M N/A Details
8/4/16 Q216 -$0.18-$0.17 -$0.01$101.5M$111.2M N/A Details
3/8/12 Q411 $0.78$0.72 +$0.06$107.95M$109.32M = Details